BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12802693)

  • 1. Intraventricular administration of recombinant tissue plasminogen activator for intraventricular hemorrhage in the newborn.
    Akisu M; Yalaz M; Arslanoglu S; Kultursay N
    Neurosurg Rev; 2003 Oct; 26(4):266-8. PubMed ID: 12802693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus.
    Whitelaw A; Saliba E; Fellman V; Mowinckel MC; Acolet D; Marlow N
    Arch Dis Child Fetal Neonatal Ed; 1996 Jul; 75(1):F20-6. PubMed ID: 8795351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular administration of human recombinant plasminogen activator for posthemorrhagic hydrocephalus of the newborn.
    Nowak S; Rudecka M; Polis L
    Acta Paediatr; 1999 Mar; 88(3):348-9. PubMed ID: 10229053
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraventricular administration of rt-PA in patients with intraventricular hemorrhage.
    Fountas KN; Kapsalaki EZ; Parish DC; Smith B; Smisson HF; Johnston KW; Robinson JS
    South Med J; 2005 Aug; 98(8):767-73. PubMed ID: 16144170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of posthemorrhagic hydrocephalus with intraventricular administration of recombinant plasminogen activator (rt-PA) and dexamethasone--possible prevention of permanent shunt implantation?].
    Erler T; Kläber HG
    Z Geburtshilfe Neonatol; 2001; 205(1):27-32. PubMed ID: 11253732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis?
    Whitelaw A; Mowinckel MC; Abildgaard U
    Acta Paediatr; 1995 Aug; 84(8):933-6. PubMed ID: 7488820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic agents in the management of posthemorrhagic hydrocephalus in preterm infants: the evidence.
    Haines SJ; Lapointe M
    Childs Nerv Syst; 1999 May; 15(5):226-34. PubMed ID: 10392493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal urokinase as a treatment for intraventricular hemorrhage in the preterm infant.
    Hudgins RJ; Boydston WR; Hudgins PA; Morris R; Adler SM; Gilreath CL
    Pediatr Neurosurg; 1997 Jun; 26(6):281-7. PubMed ID: 9485155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraventricular fibrinolysis and lumbar drainage for ventricular hemorrhage.
    Staykov D; Huttner HB; Struffert T; Ganslandt O; Doerfler A; Schwab S; Bardutzky J
    Stroke; 2009 Oct; 40(10):3275-80. PubMed ID: 19679848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid plasminogen activator inhibitor-1: a prognostic factor in posthaemorrhagic hydrocephalus.
    Hansen A; Whitelaw A; Lapp C; Brugnara C
    Acta Paediatr; 1997 Sep; 86(9):995-8. PubMed ID: 9343282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraventricular urokinase for the treatment of posthemorrhagic hydrocephalus.
    Hansen AR; Volpe JJ; Goumnerova LC; Madsen JR
    Pediatr Neurol; 1997 Oct; 17(3):213-7. PubMed ID: 9390696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta1: a possible signal molecule for posthemorrhagic hydrocephalus?
    Whitelaw A; Christie S; Pople I
    Pediatr Res; 1999 Nov; 46(5):576-80. PubMed ID: 10541321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of posthemorrhagic hydrocephalus in the preterm infant with a ventricular access device.
    Hudgins RJ; Boydston WR; Gilreath CL
    Pediatr Neurosurg; 1998 Dec; 29(6):309-13. PubMed ID: 9973678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of intraventricular hemorrhage in the premature infant with urokinase. A preliminary report.
    Hudgins RJ; Boydston WR; Hudgins PA; Adler SR
    Pediatr Neurosurg; 1994; 20(3):190-7. PubMed ID: 8204494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traumatic intraventricular hemorrhage treated with intraventricular recombinant-tissue plasminogen activator: technical case report.
    Grabb PA
    Neurosurgery; 1998 Oct; 43(4):966-9. PubMed ID: 9766330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue plasminogen activator in the treatment of intraventricular hemorrhage secondary to periventricular arteriovenous malformation before surgery: case report.
    Kumar K; Demeria DD; Verma A
    Neurosurgery; 2003 Apr; 52(4):964-8; discussion 968-9. PubMed ID: 12657195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraventricular streptokinase for the treatment of posthaemorrhagic hydrocephalus of preterm.
    Yapicioğlu H; Narli N; Satar M; Soyupak S; Altunbaşak S
    J Clin Neurosci; 2003 May; 10(3):297-9. PubMed ID: 12763331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of intraventricular blood clot with urokinase in a canine model: Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus.
    Pang D; Sclabassi RJ; Horton JA
    Neurosurgery; 1986 Oct; 19(4):553-72. PubMed ID: 3491340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraventricular streptokinase infusion in acute post-haemorrhagic hydrocephalus.
    Luciano R; Tortorolo L; Chiaretti A; Piastra M; Velardi F; Polidori G
    Intensive Care Med; 1998 May; 24(5):526-9. PubMed ID: 9660271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator.
    Mayfrank L; Kim Y; Kissler J; Delsing P; Gilsbach JM; Schröder JM; Weis J
    Acta Neuropathol; 2000 Nov; 100(5):561-7. PubMed ID: 11045679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.